Peak Capital Management’s Medtronic MDT Stock Holding History

Peak Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-250	Closed	-$21K	–	121
2018 Q2	$21K	Buy	+250	New	+$20.9K	0.01%	116

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Peak Capital Management's MDT Position: Q3 2018 in Review

Peak Capital Management sold out of Medtronic (MDT) in Q3 2018, closing a stake of 250 shares — an estimated $21K sold.

Peak Capital Management first reported a position in MDT in Q2 2018 and held it in 1 quarter. The position peaked at $21K in Q2 2018. 1,484 funds tracked by Wall St. Rank hold MDT as of Q3 2018.

Peak Capital Management reported no remaining Medtronic position as of Q3 2018 after selling out during the quarter.
Peak Capital Management sold 250 Medtronic shares in Q3 2018, an estimated $21K.
Peak Capital Management first reported a position in Medtronic in Q2 2018 and held it in 1 quarter.
Peak Capital Management's Medtronic position peaked at $21K in Q2 2018.
1,484 funds tracked by Wall St. Rank held Medtronic as of Q3 2018.

Based on Peak Capital Management's 13F filing for Q3 2018, filed 20 Nov 2018.